← Back to Search

Device

Active Treatment for Plaque Psoriasis

N/A
Waitlist Available
Research Sponsored by Thync Global, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 16
Awards & highlights

Study Summary

This is a 16-week, prospective, multicenter, double-blind, controlled, randomized study assessing change in psoriasis severity and level of stress in patients with moderate psoriasis treated with ANM. Psoriasis severity and stress levels will be measured at Weeks 0, 2, 8, 12, and 16.

Eligible Conditions
  • Plaque Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
BSA x sPGA average percent change from Baseline
Secondary outcome measures
BSA change from Baseline
DLQI change from Baseline
HADS change from Baseline
+10 more
Other outcome measures
sPGA responder rate (i.e., proportion of subjects achieving sPGA 0 or 1)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active TreatmentActive Control1 Intervention
Active stimulation pulsed current delivered over 15 minutes.
Group II: Control TreatmentPlacebo Group1 Intervention
Active stimulation pulsed current (alternative frequency) delivered over 15 minutes.

Find a Location

Who is running the clinical trial?

ethica Clinical Research Inc.Industry Sponsor
19 Previous Clinical Trials
1,719 Total Patients Enrolled
Thync Global, Inc.Lead Sponsor
1 Previous Clinical Trials
36 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis
2018. "Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03817164.
All > Psoriasis > Plaque Psoriasis
~17 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top